In our study, counts of TIM-3+ subsets in BM T cells did not differ depending on MM status, but, contrariwise, the percentage of CD8+TIM-3+ T cells among BM lymphocytes was higher in patients with progressive disease, presumably, due to the higher CD8+ cell proportion in the BM of that group. The gene discussed is CD8A; the disease is Miyoshi myopathy.